Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by the loss of dopaminergic neurons. The vast majority of PD patients develop the disease sporadically and it is assumed that the cause lies in polygenic and environmental components. The overall polygenic ri...
Main Authors: | Mohammad Dehestani, Hui Liu, Thomas Gasser |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/10/1030 |
Similar Items
-
Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease
by: Esther Yoon, et al.
Published: (2023-04-01) -
Editorial on polygenic risk scores: Colloquium held at the Centre for Personalised Medicine, Oxford
by: Padraig Dixon, et al.
Published: (2023-01-01) -
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
by: Sebastian Koch, et al.
Published: (2021-11-01) -
Derivation and Validation of Genome‐Wide Polygenic Score for Ischemic Heart Failure
by: Ishan Paranjpe, et al.
Published: (2021-11-01) -
Polygene Risk Scores
by: James Woodward, et al.
Published: (2023-07-01)